This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market, which (for the purposes of this report) includes the following
5 segments:  i.) pulse oximetry, ii.) cerebral oximetry, iii.) brain function monitors, iv.) hemodynamic monitoring devices, and v.) multi-parameter vital signs monitoring systems.

In 2014, the largest segment—vital signs monitors—comprised the vast majority of sales, at approximately 51.6% of the total market, followed by pulse oximetry devices (comprising 29.9%), hemodynamic/cardiac output monitoring devices (10.3%), cerebral oximetry devices (4.6%), and brain function monitoring devices (3.6%). Overall, this large and burgeoning market is growing at a better-than-average compound annual rate of nearly 5%.

As the intensity of care and acuity of patients admitted to hospitals increases amid ongoing nursing shortages, hospital budget constraints, and decreasing hospital lengths of stay, the need for more efficient patient monitoring will continue to increase, especially to patients with life-threatening conditions.  Despite the lingering economic uncertainty and financial constraints that have affected many medical device markets, next-generation noninvasive and minimally invasive patient monitoring products will remain in great demand, particularly those that provide more accurate algorithms, real-time monitoring and alerts, easier-to-use functions, portability throughout the continuum of care (from hospital critical care to less acute settings, as well as home monitoring), remote access/wireless capabilities and wearability, smarter alarms, enhanced vital sign trending and analysis, improved electronic medical record management and seamless transfer of patient data and alerts to clinicians, and other advanced features.

This dynamic, new report from Medtech Insight includes a profile of dozens of selected leading, new or emerging products, a comprehensive market analysis, including expected segment growth, drivers/limiters, and market forecasts (from 2014-2019), competitive analysis including 2014 market share by supplier, and opportunities. Specifically, this report covers noninvasive/minimally invasive patient monitoring devices, including:  pulse oximetry devices; cerebral oximetry devices; brain function monitoring devices (noninvasive brain function monitors and sensors to assess patient level-of-consciousness); hemodynamic monitoring devices (pulmonary artery catheters [PACs] and noninvasive/minimally invasive cardiac output [CO] monitoring systems); and vital signs monitoring systems (modular, portable, and telemetry multi-parameter vital signs monitoring systems). Additionally, emerging “wearables” or remote patient monitoring devices are also discussed, a fast-growing area of technological development.